Inventor · disambiguated record
Pravin S. Shirude
Also filed as: SHIRUDE PRAVIN · SHIRUDE PRAVIN S · SHIRUDE PRAVIN SUDHAKAR
21 granted patents·11 pending applications·104 citations·filing 2014–2025
94Inventor score
Files withBRISTOL MYERS SQUIBB CO19CV6 THERAPEUTICS NI LTD8UNIV SOUTHERN CALIFORNIA4GLOBAL ALLIANCE FOR TB DRUG DEV1
Top patents by PatentIndex Score
32 records- 0197US10570098B2Hydantoin containing deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2016·Granted Feb 25, 2020·14 cites·20 claims
- 0297US10562860B2Hydantoin containing deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2018·Granted Feb 18, 2020·15 cites·12 claims
- 0396US11124485B2Deoxyuridine triphosphatase inhibitors containing cyclopropano linkageCV6 THERAPEUTICS NI LTD·Filed 2020·Granted Sep 21, 2021·4 cites·5 claims
- 0496US11104649B2Hydantoin containing deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2020·Granted Aug 31, 2021·4 cites·19 claims
- 0596US10577321B2Deoxyuridine triphosphatase inhibitorsUNIV SOUTHERN CALIFORNIA·Filed 2016·Granted Mar 3, 2020·15 cites·17 claims
- 0696US10570100B2Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkageUNIV SOUTHERN CALIFORNIA·Filed 2016·Granted Feb 25, 2020·14 cites·12 claims
- 0796US10544105B2Deoxyuridine triphosphatase inhibitors containing cyclopropano linkageCV6 THERAPEUTICS NI LTD·Filed 2016·Granted Jan 28, 2020·14 cites·10 claims
- 0895US11198677B2Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkageUNIV SOUTHERN CALIFORNIA·Filed 2020·Granted Dec 14, 2021·4 cites·17 claims
- 0994US12098133B2Hydantoin containing deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2022·Granted Sep 24, 2024·1 cites·19 claims
- 1089US11584723B2Hydantoin containing deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2021·Granted Feb 21, 2023·1 cites·20 claims
- 1188US10676431B2Phenylpyrrolidinone formyl peptide 2 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 9, 2020·6 cites·53 claims
- 1288US2025188039A1Hydantoin containing deoxyuridine triphosphatase inhibitorsCV6 THERAPEUTICS NI LTD·Filed 2024·Application pending·0 cites
- 1385US11117861B2Phenylpyrrolidinone formyl peptide 2 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Sep 14, 2021·2 cites·15 claims
- 1484US11708327B2Phenylpyrrolidinone formyl peptide 2 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jul 25, 2023·1 cites·16 claims
- 1584US10717708B2Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jul 21, 2020·3 cites·12 claims
- 1680US11186544B2Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 30, 2021·2 cites·6 claims
- 1776US2025163046A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1876US2025154148A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1972US11008301B2Piperidinone formyl peptide 2 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 18, 2021·1 cites·9 claims
- 2068US2025250271A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 2165US10787450B2Spiro-fused cyclic ureas as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 29, 2020·1 cites·13 claims
- 2264US2024199584A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 2361US11530183B2Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Dec 20, 2022·0 cites·12 claims
- 2461US11479531B2Deoxyuridine triphosphatase inhibitorsUNIV SOUTHERN CALIFORNIA·Filed 2020·Granted Oct 25, 2022·0 cites·19 claims
- 2560US9163020B2Azaindole compounds, synthesis thereof, and methods of using the sameGLOBAL ALLIANCE FOR TB DRUG DEV·Filed 2014·Granted Oct 20, 2015·2 cites·26 claims
- 2658US2024217982A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2758US2024317769A1Kras g12d inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2853US2021163443A1Febrifugine DerivativesBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2950US2022298186A1Biaryl dialkyl phosphine oxide fpr2 agonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 3049US2023348426A1Oxopyrrolidine fpr2 agonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 3144US2021122746A1Febrifugine derivativesBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 3241US11124494B2Aryl heterocyclic piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 21, 2021·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →